Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Spire

Showing results (251-260 of 335) with videos related to

Pageof 34
Sort By:
Plos One|May 8, 2025
Correction: Susceptibility to Transmitting HIV in Patients Initiating Antiretroviral Therapy in Rural District Hospitals in Cameroon (Stratall ANRS 12110/ESTHER Trial)Gilbert Ndziessi, Julien Cohen, Charles Kouanfack, et al.
BMC Infectious Diseases|January 17, 2020
Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM)Florian Liégeois, Sylvie Boyer, Sabrina Eymard-Duvernay, et al.
Human Vaccines & Immunotherapeutics|December 14, 2023
Gradient of vaccine hesitancy among French men having sex with men: An electronic cross-sectional survey in 2022Emeline Brosset, Lisa Fressard, Chloé Cogordan, et al.
AIDS (London, England)|April 21, 2026
Temporal trends in viral SetPoint and peak CD4 cell count soon after HIV-1 seroconversionNikos Pantazis, Caroline Sabin, Dominique Costagliola, et al.
AIDS Care|February 18, 2016
Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS IPERGAY trialLuis Sagaon-Teyssier, Marie Suzan-Monti, Baptiste Demoulin, et al.
AIDS Care|July 18, 2018
What will it really take to end the HIV epidemic?Sarah Skeen, Bridgette Prince, Heidi van Rooyen, et al.
Antiviral Therapy|January 30, 2013
Time patterns of adherence and long-term virological response to non-nucleoside reverse transcriptase inhibitor regimens in the Stratall ANRS 12110/ESTHER trial in CameroonMégane Meresse, Maria Patrizia Carrieri, Christian Laurent, et al.
Addiction (Abingdon, England)|April 22, 2017
Significant reductions in alcohol use after hepatitis C treatment: results from the ANRS CO13-HEPAVIH cohortRod Knight, Perrine Roux, Antoine Vilotitch, et al.
European Journal of Gastroenterology & Hepatology|April 19, 2017
Short article: Anger and quality of life in patients co-infected with HIV and hepatitis C virus: a cross-sectional study (ANRS CO13-HEPAVIH)Fabienne Marcellin, Camelia Protopopescu, Laure Esterle, et al.
AIDS (London, England)|July 16, 2019
Long-term safety and vaccine-induced seropositivity in healthy volunteers from HIV vaccine trialsChristine Durier, Corinne Desaint, Jean-Daniel Lelièvre, et al.
Pageof 34

Showing results (251-260 of 335) with videos related to

Sort By:
Pageof 34
Plos One|May 8, 2025
Correction: Susceptibility to Transmitting HIV in Patients Initiating Antiretroviral Therapy in Rural District Hospitals in Cameroon (Stratall ANRS 12110/ESTHER Trial)Gilbert Ndziessi, Julien Cohen, Charles Kouanfack, et al.
BMC Infectious Diseases|January 17, 2020
Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM)Florian Liégeois, Sylvie Boyer, Sabrina Eymard-Duvernay, et al.
Human Vaccines & Immunotherapeutics|December 14, 2023
Gradient of vaccine hesitancy among French men having sex with men: An electronic cross-sectional survey in 2022Emeline Brosset, Lisa Fressard, Chloé Cogordan, et al.
AIDS (London, England)|April 21, 2026
Temporal trends in viral SetPoint and peak CD4 cell count soon after HIV-1 seroconversionNikos Pantazis, Caroline Sabin, Dominique Costagliola, et al.
AIDS Care|February 18, 2016
Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS IPERGAY trialLuis Sagaon-Teyssier, Marie Suzan-Monti, Baptiste Demoulin, et al.
AIDS Care|July 18, 2018
What will it really take to end the HIV epidemic?Sarah Skeen, Bridgette Prince, Heidi van Rooyen, et al.
Antiviral Therapy|January 30, 2013
Time patterns of adherence and long-term virological response to non-nucleoside reverse transcriptase inhibitor regimens in the Stratall ANRS 12110/ESTHER trial in CameroonMégane Meresse, Maria Patrizia Carrieri, Christian Laurent, et al.
Addiction (Abingdon, England)|April 22, 2017
Significant reductions in alcohol use after hepatitis C treatment: results from the ANRS CO13-HEPAVIH cohortRod Knight, Perrine Roux, Antoine Vilotitch, et al.
European Journal of Gastroenterology & Hepatology|April 19, 2017
Short article: Anger and quality of life in patients co-infected with HIV and hepatitis C virus: a cross-sectional study (ANRS CO13-HEPAVIH)Fabienne Marcellin, Camelia Protopopescu, Laure Esterle, et al.
AIDS (London, England)|July 16, 2019
Long-term safety and vaccine-induced seropositivity in healthy volunteers from HIV vaccine trialsChristine Durier, Corinne Desaint, Jean-Daniel Lelièvre, et al.
Pageof 34